Stay updated on Darolutamide+Standard Therapy in High-Risk Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Darolutamide+Standard Therapy in High-Risk Prostate Cancer Clinical Trial page.

Latest updates to the Darolutamide+Standard Therapy in High-Risk Prostate Cancer Clinical Trial page
- Check4 days agoChange DetectedThe study history now shows a note that no longer looking for participants and a page revision to v3.6.0; the previous revision v3.5.5 was removed. This indicates an official recruitment status update and a new version of the study record.SummaryDifference0.2%

- Check11 days agoChange DetectedA new revision entry v3.5.5 was added to the record history and the previous v3.5.4 entry was removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe record history adds a new revision label v3.5.4 and removes v3.5.3, reflecting an update to the study's version history. This change is a metadata update and does not modify study data or content.SummaryDifference0.1%

- Check40 days agoChange DetectedNew version 43 was added on 2026-05-04 with updates to the Study Status. A subsequent 2026-05-06 entry added further Study Status details, and the 2023-07-28 version was removed.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page’s revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a minor platform change rather than an update to the trial record details.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed in the version history.SummaryDifference0.1%

Stay in the know with updates to Darolutamide+Standard Therapy in High-Risk Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide+Standard Therapy in High-Risk Prostate Cancer Clinical Trial page.